ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids

Clinical trial NCT05629702 · RECRUITING

Trial details

NCT number: NCT05629702
Sponsor: University of Birmingham
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Brain Tumor Cannabis Brain Tumor, Recurrent

Start date: 2023-02-03
Primary completion: 2026-09-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.